Abstract
This article aimed to quantify the characteristics of antiparasitic drug treatment coalescent to surgical treatment in hepatic hydatid cyst. The therapeutic management of hepatic hydatid disease is not yet standardized, hence the absence of the ideal technique with applicability in a specific situation and whose outcome is permanently the same.
Hydatid pathology is remarkably heteromorphic in terms of location in the human body but also in terms of the anatomopathological transformations it produces.
Hepatic hydatid cyst is a pathology far from being eradicated in developing countries, while in most developed countries, this disease is an exodus. Therefore, the discovery of the most suitable, effective and appropriate therapeutic means, which have rapid, effective and safe applicability, belongs to those who are still struggling with this pathology. Therefore the motivation and responsibility for finding the most effective, adapted and appropriate therapeutic means, which successfully pass the test of speed of cure, belongs to those who are still facing the liver disease.